nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Vismodegib—Sorafenib—liver cancer	0.883	1	CrCrCtD
Tolvaptan—ABCB1—Sorafenib—liver cancer	0.011	0.389	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—liver cancer	0.00666	0.236	CbGbCtD
Tolvaptan—CYP3A4—Sorafenib—liver cancer	0.00658	0.233	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—liver cancer	0.00399	0.142	CbGbCtD
Tolvaptan—Rhabdomyolysis—Sorafenib—liver cancer	0.00134	0.0284	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Sorafenib—liver cancer	0.00126	0.0266	CcSEcCtD
Tolvaptan—Prothrombin level increased—Epirubicin—liver cancer	0.00107	0.0226	CcSEcCtD
Tolvaptan—Zafirlukast—CYP2E1—liver cancer	0.000998	0.682	CrCbGaD
Tolvaptan—Prothrombin level increased—Doxorubicin—liver cancer	0.00099	0.0209	CcSEcCtD
Tolvaptan—Hyponatraemia—Sorafenib—liver cancer	0.000866	0.0183	CcSEcCtD
Tolvaptan—Hypernatraemia—Epirubicin—liver cancer	0.000835	0.0177	CcSEcCtD
Tolvaptan—Dehydration—Sorafenib—liver cancer	0.000802	0.017	CcSEcCtD
Tolvaptan—Breast disorder—Sorafenib—liver cancer	0.000779	0.0165	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000776	0.0164	CcSEcCtD
Tolvaptan—Hypernatraemia—Doxorubicin—liver cancer	0.000773	0.0163	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00076	0.0161	CcSEcCtD
Tolvaptan—Renal failure—Sorafenib—liver cancer	0.000653	0.0138	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Epirubicin—liver cancer	0.000593	0.0125	CcSEcCtD
Tolvaptan—Urinary tract disorder—Sorafenib—liver cancer	0.000589	0.0125	CcSEcCtD
Tolvaptan—Connective tissue disorder—Sorafenib—liver cancer	0.000586	0.0124	CcSEcCtD
Tolvaptan—Urethral disorder—Sorafenib—liver cancer	0.000585	0.0124	CcSEcCtD
Tolvaptan—Cardiac disorder—Sorafenib—liver cancer	0.000554	0.0117	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000549	0.0116	CcSEcCtD
Tolvaptan—Angiopathy—Sorafenib—liver cancer	0.000541	0.0114	CcSEcCtD
Tolvaptan—Immune system disorder—Sorafenib—liver cancer	0.000539	0.0114	CcSEcCtD
Tolvaptan—Mediastinal disorder—Sorafenib—liver cancer	0.000538	0.0114	CcSEcCtD
Tolvaptan—Malnutrition—Sorafenib—liver cancer	0.000519	0.011	CcSEcCtD
Tolvaptan—Dysgeusia—Sorafenib—liver cancer	0.000509	0.0108	CcSEcCtD
Tolvaptan—Hyperuricaemia—Epirubicin—liver cancer	0.000473	0.01	CcSEcCtD
Tolvaptan—Syncope—Sorafenib—liver cancer	0.000466	0.00985	CcSEcCtD
Tolvaptan—Vismodegib—ALB—liver cancer	0.000465	0.317	CrCbGaD
Tolvaptan—Blood bilirubin increased—Epirubicin—liver cancer	0.000464	0.00982	CcSEcCtD
Tolvaptan—Loss of consciousness—Sorafenib—liver cancer	0.000456	0.00965	CcSEcCtD
Tolvaptan—Blood uric acid increased—Epirubicin—liver cancer	0.000447	0.00945	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000439	0.00928	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—liver cancer	0.000439	0.00928	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—liver cancer	0.000438	0.00926	CcSEcCtD
Tolvaptan—Dry mouth—Sorafenib—liver cancer	0.000432	0.00914	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—liver cancer	0.000431	0.00912	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—liver cancer	0.000429	0.00908	CcSEcCtD
Tolvaptan—Anaphylactic shock—Sorafenib—liver cancer	0.000424	0.00896	CcSEcCtD
Tolvaptan—Shock—Sorafenib—liver cancer	0.000417	0.00882	CcSEcCtD
Tolvaptan—Nervous system disorder—Sorafenib—liver cancer	0.000416	0.00879	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—liver cancer	0.000414	0.00875	CcSEcCtD
Tolvaptan—Skin disorder—Sorafenib—liver cancer	0.000412	0.00871	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—liver cancer	0.000406	0.00859	CcSEcCtD
Tolvaptan—Anorexia—Sorafenib—liver cancer	0.000404	0.00854	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—liver cancer	0.000399	0.00844	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—liver cancer	0.000397	0.00839	CcSEcCtD
Tolvaptan—Decreased appetite—Sorafenib—liver cancer	0.000368	0.00779	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—liver cancer	0.000367	0.00777	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Sorafenib—liver cancer	0.000366	0.00774	CcSEcCtD
Tolvaptan—Constipation—Sorafenib—liver cancer	0.000362	0.00766	CcSEcCtD
Tolvaptan—Body temperature increased—Sorafenib—liver cancer	0.000335	0.00708	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—liver cancer	0.000335	0.00708	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—liver cancer	0.000327	0.00691	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—liver cancer	0.000325	0.00688	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—liver cancer	0.00032	0.00677	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000319	0.00674	CcSEcCtD
Tolvaptan—Hypersensitivity—Sorafenib—liver cancer	0.000312	0.0066	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—liver cancer	0.00031	0.00655	CcSEcCtD
Tolvaptan—Asthenia—Sorafenib—liver cancer	0.000304	0.00643	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—liver cancer	0.000302	0.00639	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—liver cancer	0.000301	0.00636	CcSEcCtD
Tolvaptan—Pruritus—Sorafenib—liver cancer	0.0003	0.00634	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—liver cancer	0.000299	0.00631	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—liver cancer	0.000296	0.00627	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—liver cancer	0.000296	0.00626	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000295	0.00624	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—liver cancer	0.000291	0.00615	CcSEcCtD
Tolvaptan—Diarrhoea—Sorafenib—liver cancer	0.00029	0.00613	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—liver cancer	0.000288	0.00609	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000287	0.00607	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000281	0.00594	CcSEcCtD
Tolvaptan—Dizziness—Sorafenib—liver cancer	0.00028	0.00593	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—liver cancer	0.000276	0.00584	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—liver cancer	0.000274	0.0058	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—liver cancer	0.000269	0.0057	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—liver cancer	0.000266	0.00563	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000266	0.00562	CcSEcCtD
Tolvaptan—Headache—Sorafenib—liver cancer	0.000265	0.00561	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00026	0.0055	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—liver cancer	0.000254	0.00538	CcSEcCtD
Tolvaptan—Nausea—Sorafenib—liver cancer	0.000252	0.00532	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—liver cancer	0.000248	0.00525	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—liver cancer	0.000241	0.00511	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—liver cancer	0.000235	0.00498	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—liver cancer	0.00023	0.00486	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—liver cancer	0.000223	0.00472	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—liver cancer	0.000218	0.0046	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—liver cancer	0.000217	0.00458	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—liver cancer	0.000216	0.00457	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—liver cancer	0.000205	0.00433	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—liver cancer	0.000201	0.00426	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—liver cancer	0.0002	0.00424	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—liver cancer	0.0002	0.00423	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—liver cancer	0.0002	0.00423	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—liver cancer	0.000199	0.00421	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—liver cancer	0.000199	0.0042	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—liver cancer	0.000192	0.00406	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—liver cancer	0.000189	0.004	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—liver cancer	0.000188	0.00397	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—liver cancer	0.000185	0.00391	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—liver cancer	0.000184	0.0039	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—liver cancer	0.000184	0.00389	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—liver cancer	0.000178	0.00377	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—liver cancer	0.000178	0.00376	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—liver cancer	0.000174	0.00368	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—liver cancer	0.000173	0.00366	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—liver cancer	0.000172	0.00364	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—liver cancer	0.000169	0.00357	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—liver cancer	0.000165	0.00348	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000162	0.00343	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—liver cancer	0.000161	0.00341	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—liver cancer	0.00016	0.00339	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—liver cancer	0.00016	0.00338	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—liver cancer	0.000159	0.00337	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—liver cancer	0.000157	0.00331	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—liver cancer	0.000156	0.0033	CcSEcCtD
Tolvaptan—Shock—Epirubicin—liver cancer	0.000154	0.00326	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—liver cancer	0.000154	0.00325	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—liver cancer	0.000152	0.00322	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00015	0.00317	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—liver cancer	0.000149	0.00316	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—liver cancer	0.000149	0.00316	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—liver cancer	0.000148	0.00313	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—liver cancer	0.000145	0.00306	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—liver cancer	0.000143	0.00302	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—liver cancer	0.000142	0.00301	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—liver cancer	0.000141	0.00298	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—liver cancer	0.000138	0.00292	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—liver cancer	0.000136	0.00288	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000135	0.00286	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—liver cancer	0.000134	0.00283	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—liver cancer	0.000129	0.00273	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—liver cancer	0.000126	0.00266	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000125	0.00265	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—liver cancer	0.000124	0.00262	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—liver cancer	0.000124	0.00262	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—liver cancer	0.000119	0.00253	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—liver cancer	0.000115	0.00244	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—liver cancer	0.000115	0.00242	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—liver cancer	0.000112	0.00238	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—liver cancer	0.000111	0.00234	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—liver cancer	0.000107	0.00227	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—liver cancer	0.000107	0.00226	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—liver cancer	0.000104	0.0022	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—liver cancer	0.000104	0.00219	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—liver cancer	0.000103	0.00217	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—liver cancer	9.92e-05	0.0021	CcSEcCtD
Tolvaptan—Headache—Epirubicin—liver cancer	9.81e-05	0.00207	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—liver cancer	9.58e-05	0.00203	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—liver cancer	9.3e-05	0.00197	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—liver cancer	9.08e-05	0.00192	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—liver cancer	8.61e-05	0.00182	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CSF2—liver cancer	6.32e-05	0.00159	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	6.3e-05	0.00159	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CSF2—liver cancer	6.28e-05	0.00158	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	6.16e-05	0.00155	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	6.15e-05	0.00155	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTA4—liver cancer	6.09e-05	0.00154	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	6.07e-05	0.00153	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	6e-05	0.00151	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTA2—liver cancer	5.93e-05	0.0015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CSF2—liver cancer	5.74e-05	0.00145	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTA1—liver cancer	5.72e-05	0.00144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CSF2—liver cancer	5.7e-05	0.00144	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—NAT2—liver cancer	5.66e-05	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—liver cancer	5.6e-05	0.00141	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	5.58e-05	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADAM17—liver cancer	5.26e-05	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADAM17—liver cancer	5.23e-05	0.00132	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—RAF1—liver cancer	5.07e-05	0.00128	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	5.06e-05	0.00128	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	4.99e-05	0.00126	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	4.96e-05	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—liver cancer	4.96e-05	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PSMA4—liver cancer	4.95e-05	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PSMD10—liver cancer	4.95e-05	0.00125	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—liver cancer	4.93e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PSMA4—liver cancer	4.91e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PSMD10—liver cancer	4.91e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CG—liver cancer	4.75e-05	0.0012	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	4.75e-05	0.0012	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CG—liver cancer	4.71e-05	0.00119	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	4.64e-05	0.00117	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—HPGDS—liver cancer	4.52e-05	0.00114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—liver cancer	4.51e-05	0.00114	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—liver cancer	4.47e-05	0.00113	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	4.44e-05	0.00112	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	4.43e-05	0.00112	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—liver cancer	4.42e-05	0.00112	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—liver cancer	4.42e-05	0.00111	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	4.34e-05	0.00109	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CG—liver cancer	4.31e-05	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CG—liver cancer	4.28e-05	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	4.24e-05	0.00107	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	4.24e-05	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CD—liver cancer	4.17e-05	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CD—liver cancer	4.14e-05	0.00105	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	4.01e-05	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCE—liver cancer	3.83e-05	0.000967	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	3.81e-05	0.00096	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCE—liver cancer	3.81e-05	0.00096	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CD—liver cancer	3.79e-05	0.000956	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CD—liver cancer	3.76e-05	0.000949	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—liver cancer	3.75e-05	0.000947	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2E1—liver cancer	3.69e-05	0.00093	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CB—liver cancer	3.64e-05	0.000918	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	3.64e-05	0.000917	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—liver cancer	3.63e-05	0.000916	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CB—liver cancer	3.61e-05	0.000911	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—liver cancer	3.61e-05	0.000909	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—liver cancer	3.45e-05	0.000869	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CSF2—liver cancer	3.39e-05	0.000855	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GGT1—liver cancer	3.39e-05	0.000854	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—RAF1—liver cancer	3.38e-05	0.000853	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CSF2—liver cancer	3.37e-05	0.000849	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RAF1—liver cancer	3.36e-05	0.000847	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—H2AFX—liver cancer	3.34e-05	0.000843	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—liver cancer	3.34e-05	0.000843	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	3.34e-05	0.000842	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—H2AFX—liver cancer	3.32e-05	0.000837	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—liver cancer	3.32e-05	0.000837	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CB—liver cancer	3.3e-05	0.000833	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CB—liver cancer	3.28e-05	0.000827	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	3.28e-05	0.000826	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—liver cancer	3.22e-05	0.000811	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UGDH—liver cancer	3.22e-05	0.000811	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	3.1e-05	0.000781	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTP1—liver cancer	3.04e-05	0.000767	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—liver cancer	3.03e-05	0.000765	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EPT1—liver cancer	3.02e-05	0.000763	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—liver cancer	3.02e-05	0.000762	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—liver cancer	3.01e-05	0.00076	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—liver cancer	3e-05	0.000757	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	3e-05	0.000757	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TAT—liver cancer	2.87e-05	0.000723	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.8e-05	0.000705	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	2.77e-05	0.000698	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—liver cancer	2.77e-05	0.000697	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.76e-05	0.000695	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK14—liver cancer	2.75e-05	0.000693	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—liver cancer	2.75e-05	0.000692	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK14—liver cancer	2.73e-05	0.000688	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ESR1—liver cancer	2.69e-05	0.00068	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ESR1—liver cancer	2.68e-05	0.000675	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—liver cancer	2.66e-05	0.000671	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.65e-05	0.000668	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—liver cancer	2.64e-05	0.000666	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.61e-05	0.000659	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—liver cancer	2.55e-05	0.000642	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APC—liver cancer	2.55e-05	0.000642	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APC—liver cancer	2.53e-05	0.000638	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—liver cancer	2.53e-05	0.000638	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	2.43e-05	0.000613	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—liver cancer	2.39e-05	0.000604	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—liver cancer	2.38e-05	0.000599	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—liver cancer	2.24e-05	0.000565	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	2.23e-05	0.000562	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—liver cancer	2.22e-05	0.000561	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—liver cancer	2.22e-05	0.000559	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—liver cancer	2.21e-05	0.000559	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—liver cancer	2.2e-05	0.000555	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—liver cancer	2.2e-05	0.000555	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—liver cancer	2.19e-05	0.000553	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	2.18e-05	0.000551	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—liver cancer	2.18e-05	0.000549	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	2.13e-05	0.000536	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	2.12e-05	0.000535	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	2.1e-05	0.000531	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	2.06e-05	0.000518	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	2.05e-05	0.000516	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—liver cancer	2.01e-05	0.000508	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	2.01e-05	0.000506	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—liver cancer	2e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RAF1—liver cancer	2e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RAF1—liver cancer	1.98e-05	0.000501	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UGDH—liver cancer	1.98e-05	0.0005	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTOR—liver cancer	1.95e-05	0.000492	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—liver cancer	1.95e-05	0.000492	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1B—liver cancer	1.95e-05	0.000491	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GLUL—liver cancer	1.95e-05	0.000491	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTOR—liver cancer	1.94e-05	0.000489	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—liver cancer	1.94e-05	0.000489	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NR1H4—liver cancer	1.88e-05	0.000474	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—liver cancer	1.86e-05	0.00047	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EPT1—liver cancer	1.86e-05	0.00047	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.85e-05	0.000467	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—liver cancer	1.85e-05	0.000467	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA3—liver cancer	1.85e-05	0.000466	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—liver cancer	1.83e-05	0.000462	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—liver cancer	1.82e-05	0.000459	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—liver cancer	1.81e-05	0.000457	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—liver cancer	1.8e-05	0.000454	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—liver cancer	1.8e-05	0.000453	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—liver cancer	1.79e-05	0.000452	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—liver cancer	1.78e-05	0.00045	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—liver cancer	1.78e-05	0.000449	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—liver cancer	1.78e-05	0.000449	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.78e-05	0.000448	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—liver cancer	1.77e-05	0.000447	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TAT—liver cancer	1.77e-05	0.000445	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—liver cancer	1.75e-05	0.000441	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—liver cancer	1.74e-05	0.00044	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—liver cancer	1.73e-05	0.000437	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—liver cancer	1.73e-05	0.000437	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CTNNB1—liver cancer	1.73e-05	0.000436	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CTNNB1—liver cancer	1.72e-05	0.000433	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.7e-05	0.00043	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.7e-05	0.000429	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—liver cancer	1.7e-05	0.000428	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—liver cancer	1.69e-05	0.000426	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA4—liver cancer	1.69e-05	0.000426	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—liver cancer	1.68e-05	0.000425	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—liver cancer	1.68e-05	0.000423	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—liver cancer	1.65e-05	0.000416	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA2—liver cancer	1.65e-05	0.000415	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—liver cancer	1.65e-05	0.000415	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—liver cancer	1.64e-05	0.000413	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—liver cancer	1.63e-05	0.000412	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA1—liver cancer	1.59e-05	0.000401	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.59e-05	0.0004	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.58e-05	0.000397	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAT2—liver cancer	1.57e-05	0.000396	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—liver cancer	1.52e-05	0.000384	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—liver cancer	1.51e-05	0.000381	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—liver cancer	1.51e-05	0.00038	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOB—liver cancer	1.51e-05	0.00038	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—liver cancer	1.5e-05	0.000378	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.45e-05	0.000365	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CRABP1—liver cancer	1.44e-05	0.000362	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.44e-05	0.000362	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—liver cancer	1.4e-05	0.000353	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.4e-05	0.000353	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—liver cancer	1.4e-05	0.000353	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—liver cancer	1.39e-05	0.000351	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—liver cancer	1.39e-05	0.00035	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—liver cancer	1.3e-05	0.000327	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—liver cancer	1.29e-05	0.000324	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HPGDS—liver cancer	1.26e-05	0.000317	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1B—liver cancer	1.2e-05	0.000303	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GLUL—liver cancer	1.2e-05	0.000303	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—liver cancer	1.19e-05	0.0003	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.18e-05	0.000298	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—liver cancer	1.18e-05	0.000298	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NR1H4—liver cancer	1.16e-05	0.000292	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—liver cancer	1.15e-05	0.00029	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—liver cancer	1.14e-05	0.000288	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA3—liver cancer	1.14e-05	0.000287	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PSMD10—liver cancer	1.12e-05	0.000282	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PSMA4—liver cancer	1.12e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—liver cancer	1.1e-05	0.000278	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—liver cancer	1.09e-05	0.000276	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT2—liver cancer	1.09e-05	0.000275	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.07e-05	0.000269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—liver cancer	1.05e-05	0.000266	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—liver cancer	1.05e-05	0.000264	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA4—liver cancer	1.04e-05	0.000263	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2E1—liver cancer	1.02e-05	0.000258	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA2—liver cancer	1.01e-05	0.000256	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA1—liver cancer	9.79e-06	0.000247	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—liver cancer	9.72e-06	0.000245	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAT2—liver cancer	9.68e-06	0.000244	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	9.65e-06	0.000243	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—liver cancer	9.65e-06	0.000243	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYCS—liver cancer	9.58e-06	0.000242	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GGT1—liver cancer	9.4e-06	0.000237	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT1—liver cancer	9.4e-06	0.000237	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOB—liver cancer	9.28e-06	0.000234	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CRABP1—liver cancer	8.85e-06	0.000223	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—liver cancer	8.44e-06	0.000213	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—liver cancer	8.33e-06	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—liver cancer	7.76e-06	0.000196	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HPGDS—liver cancer	7.74e-06	0.000195	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—liver cancer	7.36e-06	0.000185	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PSMD10—liver cancer	6.9e-06	0.000174	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PSMA4—liver cancer	6.9e-06	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—liver cancer	6.86e-06	0.000173	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—liver cancer	6.73e-06	0.00017	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT2—liver cancer	6.71e-06	0.000169	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2E1—liver cancer	6.31e-06	0.000159	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYCS—liver cancer	5.9e-06	0.000149	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GGT1—liver cancer	5.79e-06	0.000146	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT1—liver cancer	5.79e-06	0.000146	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—liver cancer	5.76e-06	0.000145	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—liver cancer	5.56e-06	0.00014	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—liver cancer	5.2e-06	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—liver cancer	5.13e-06	0.000129	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—liver cancer	5.06e-06	0.000128	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—liver cancer	5e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—liver cancer	4.78e-06	0.000121	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—liver cancer	4.53e-06	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—liver cancer	4.41e-06	0.000111	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—liver cancer	4.22e-06	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—liver cancer	4.14e-06	0.000105	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—liver cancer	3.55e-06	8.95e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—liver cancer	3.43e-06	8.64e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—liver cancer	3.12e-06	7.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—liver cancer	3.08e-06	7.77e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—liver cancer	2.72e-06	6.86e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—liver cancer	2.69e-06	6.79e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—liver cancer	2.2e-06	5.54e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—liver cancer	1.66e-06	4.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—liver cancer	1.35e-06	3.42e-05	CbGpPWpGaD
